Systacare Remedies

You Tube Google Plus Facebook


Ceftriaxone Tazobactam Injection



Ceftriaxone Tazobactam Injection is formulated to conquer stubborn pathogens. The extensively recommended Ceftriaxone Tazobactam Injection has unmatched stability to beta-lactamases. Ceftriaxone 1000 mg / 500 mg / 250 mg + Tazobactam 125 mg / 62.5 mg / 31.25 mg Injection is meant for Im / IV use.

The Combined Attack of Two Synergistic Antibacterials In management of severe & Resistant infections :

  • Promises synergistic action of bactericidal ceftriaxone and betalactamase inhibitor Tazobactam
  • Provides broader anti-bacterial coverage
    • Tazobactam inhibits betalactamase producing bacteria & helps to incrase the spectrum of ceftriaxone
  • Achieves high conc. In CSF & tissue fluids
  • Highly effective against gram + ve, Gram – Ve bacteria & anaerobes
  • Ensures effective and safe treatment option in severe infections

 
Dosage And Administration :

  • Pediatric Patients  : Serious infections, 50-75 mg/kg (in terms of ceftriaxone) given in divided doses every 12 hours. The total daily dose should not exceed 2 gm (in terms of ceftriaxone). For the treatment of acute bacterial otitis media, a single 50 mg/kg IM (not to exceed 1 gram)
  • Adults  : 1000/125 mg of ceftriaxone / tazobactam OD (or in equally divided doses BID) total daily dose should not exceed 4 gm (in terms of ceftriaxone). For pre-operative use / surgical prophylaxis, 1gm I.V administered ½ to 2 hours before surgery for 4-14 days by deep IM, or slow IV


Indicated In :

  • Respiratory Tract Infection
  • Intrabdominal infections
    • Peritonitis,
    • Cholecystitis,
    • Cholangitis
  • Gynaecological Infections
  • - Endometritis,
  • - Gonorrhoea, - PID
  • Surgical Infections
  • Skin & Soft Tissue Infections
  • Sexually transmitted Diseases
  • Meningitis
  • Nosocomial infections
  • Bone & joint infections